Company News for Dec 1, 2020

MRNA GM NJR SPGI NKLA

  • Shares of Moderna, Inc. (MRNA - Free Report) rallied 20.2% after the company said that its COVID-19 vaccine candidate was found to be more than 94% effective and also added that it would seek emergency use authorization from the FDA.
  • Nikola Corp. (NKLA - Free Report) shares fell 26.9% after the company and General Motors Co. (GM - Free Report) announced a reworked deal leading GM to give up its equity stake in the company.
  • Shares of S&P Global Inc. (SPGI - Free Report) advanced 3% as the company said it would buy out IHS Markit Ltd. in an all-stock deal for $44 billion.
  • New Jersey Resources Corp. (NJR - Free Report) shares dipped 9.5% after the company posted fiscal fourth-quarter 2020 adjusted earnings per share of $0.57, missing the Zacks Consensus Estimate of $0.58 per share.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>